OSA in both species shares many features including the presence of microscopic metastatic disease at diagnosis, the development of chemotherapy resistant metastases, and dysregulation of several key cellular proteins including Met, ezrin and STAT3 [2-6]. This evidence concerns the gene STAT3 and obstructive sleep apnea syndrome.